The French Compassionate Program "Temporary Authorization For Use" And Thereafter... How Can It Affect Drug Market Access? von Masia, C, Degrassat-Théas, A, Parent de curzon, O, Loubière, A, Paubel, P

Volltext

Determinants of Hospitals' Attractiveness For Patients: Application to Expensive Drugs von Siorat, V, Degrassat-Théas, A, Paubel, P, Parent, de Curzon O, Sinègre, M

Volltext

Relevance of a National Forecast Growth Rate, as a Regulation Tool of the Expensive Hospital Drug Spending, in France von Monnier, R, Degrassat-Théas, A, Parent de Curzon, O, Sinègre, M

Volltext

PHP75 Is Orphan Designation a Driver of Orphan Drug Pricing? von Degrassat-Théas, A, Paubel, P, Parent de Curzon, O, Berard, F, Poisson, N, Le pen, C, Sinègre, M

Volltext

HPR14 Identifying the Key Drivers of Biosimilar Uptake in Paris University Hospitals Using a Principal Component Analysis von Boudjenah, Y, Tano, M, Siorat, V, Parent de Curzon, O, Degrassat Theas, A, Paubel, P

Volltext

HTA147 Advanced Therapy Medicinal Products (ATMPS) Market Access Challenges in France von Hoceini, K, Tano, M, Siorat, V, Parent de Curzon, O, Degrassat-Théas, A, Paubel, P

Volltext

HTA143 Drug Market Access Delays in France: What Role May Cost-Effectiveness Evaluations Play in Varying These Timescales? von Cartolano, P., Tano, M., Siorat, V., Moracchini, M., Ribault, M., Parent de Curzon, O., Paubel, P., Degrassat Theas, A.

Volltext

OP25 Developments in Anticancer Drugs Preparation Activity in Hospitals Pharmacies Units (HPU) and Their Impact on the Activity of Paris University Hospitals (AP-HP) von Moracchini, M., Tano, M., Siorat, V., Parent de Curzon, O., Paubel, P., Madelaine, I., Degrassat Theas, A.

Volltext

OP19 Monoclonal Antibodies in Oncology: A Comparative Analysis of Subcutaneous Form Use Between Paris University Hospitals (AP-HP) Versus French Hospitals von Moracchini, M., Tano, M., Siorat, V., Cartolano, P., Parent de Curzon, O., Paubel, P., Degrassat Theas, A.

Volltext

EE580 New Anti-CGRP in France: Estimated Financial Impact of Eptinezumab in Hospitals, a Prospective Stake von Cartolano, P., Tano, M., Siorat, V., Fusier, I., Moracchini, M., Parent de Curzon, O., Paubel, P., Degrassat Theas, A.

Volltext

PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate Program von Degrassat-Théas, A, Paubel, P, Parent de Curzon, O, Le Pen, C, Sinègre, M

Volltext

EE352 New Reimbursement Policy on Costly Treatments for Rehabilitation Care in France: Estimated Impact in a University Hospital von Legoupil, T, Tano, M, Siorat, V, Ribault, M, Parent de Curzon, O, Degrassat Theas, A, Paubel, P

Volltext

PRO45 Emicizumab: Extension of the Target Population and Change of the Dispensation Channel, What Financial IMPACT for the Public Hospitals of Paris? von Bouchand, C., Siorat, V., Degrassat Theas, A., Parent de Curzon, O., Paubel, P.

Volltext

POSA217 The Reform of the French Compassionate Use Program : The State and Perspective Before the Change von Zimmermann, P, Tano, M, Siorat, V, Ribault, M, Parent de Curzon, O, Degrassat-Théas, A, Paubel, P

Volltext

PIT7 RESOURCE UTILIZATION REQUIRED FOR THE USE OF PREMIXED NITROUS OXIDE IN OXYGEN INHALATION IN A LARGE PAEDIATRIC HOSPITAL SETTING von Degrassat-Théas, A., Allouche, A., Dufaÿ Wojcicki, A., Prot-Labarthe, S., Parent de Curzon, O., Bourdon, O., Boudy, V.

Volltext

PIN86 - COST SAVINGS TO BE EXPECTED FROM THE INTRODUCTION OF NEW ANTI-HIV GENERICS IN UNIVERSITY PUBLIC HOSPITALS OF PARIS von Garnier, A., Degrassat-Théas, A., Parent de Curzon, O., Poisson, N., Paubel, P.

Volltext

PRM276 - METHODOLOGICAL ISSUES OF DRUG PRICE COMPARISON STUDIES: WHAT IMPROVEMENT IN QUALITY? von Carval, G, Degrassat-Théas, A., Brizion, B, Parent de Curzon, O, Poisson, N, Paubel, P

Volltext

PHP183 - PRICE DIFFERENCE OF MEDICINES DISPENSED IN COMMUNITY PHARMACIES AND IN THE HOSPITAL SECTOR : AN ANALYSIS ON THE MEDICINES FINANCED ON THE BASIS OF HOSPITAL SERVICE TARIFFS von Laincer, A., Degrassat-Théas, A., Rouibah, F., Parent de Curzon, O., Poisson, N., Paubel, P.

Volltext

PHP72 - A NEW FRENCH FINANCIAL INCENTIVE TO BOOST INSULIN AND ETANERCEPT BIOSIMILARS PRESCRIBING: SIMULATION OF ECONOMIC IMPACTS FOR THE PUBLIC HOSPITALS OF PARIS von Adé, A., Degrassat-Théas, A., Bocquet, F., Parent de Curzon, O., Paubel, P.

Volltext

RESOURCE UTILIZATION REQUIRED FOR THE USE OF PREMIXED NITROUS OXIDE IN OXYGEN INHALATION IN A LARGE PAEDIATRIC HOSPITAL SETTING von Degrassat-Théas, A, Allouche, A, Dufaÿ Wojcicki, A, Prot-Labarthe, S, Parent de Curzon, O, Bourdon, O, Boudy, V

Volltext